Domov › Mielodisplastični sindromi › New York › New York City
Klinične študije za Mielodisplastični sindromi v New York City, NY
21 študij za Mielodisplastični sindromi išče udeležence na lokacijah v New York City in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Vključevanje udeležencevFaza 2
- Mount Sinai Hospital, New York
- Memorial Sloan Kettering Cancer Center, New York
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Vključevanje udeležencevFaza 1
- Memorial Sloan Kettering Cancer Center, New York
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Vključevanje udeležencevFaza 1
- Memorial Sloan Kettering Cancer Center, New York
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Vključevanje udeležencevFaza 1/2
- Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine at Mount Sinai, New York
- Montefiore, New York
Cord Blood Transplant in Adults With Blood Cancers
Vključevanje udeležencevFaza 2
- Memorial Sloan Kettering Cancer Center, New York
Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
Vključevanje udeležencevFaza 3
- MSKCC, New York
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Vključevanje udeležencevFaza 1/2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
Vključevanje udeležencevFaza 1
- NYU Langone Health, New York
Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)
Vključevanje udeležencevFaza 1/2
- Ichan School of Medicine at Mount Sinai, New York
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Vključevanje udeležencevFaza 1/2
- Research Site, New York
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Vključevanje udeležencevFaza 2
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
Cord Blood Transplantation in Children and Young Adults With Blood Cancer
Vključevanje udeležencevFaza 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Vključevanje udeležencevFaza 2/3
- Perlmutter Cancer Center - 34th Street, New York
- Icahn School of Medicine at Mount Sinai, New York
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
Vključevanje udeležencevFaza 1
- Icahn School of Medicine at Mount Sinai, New York
Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes
Vključevanje udeležencevFaza 1
- Memorial Sloan Kettering Cancer Center, New York
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Vključevanje udeležencevFaza 1
- New York University, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, New York
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Vključevanje udeležencevFaza 1
- Memorial Sloan Kettering Cancer Center, New York
Study of REM-422 in Patients With AML or Higher Risk MDS
Vključevanje udeležencevFaza 1
- Memorial Sloan Kettering, New York
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
Vključevanje udeležencevFaza 1
- Memorial Sloan Kettering Cancer Center, New York
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Vključevanje udeležencevFaza 1
- Memorial Sloan-Kettering Cancer Center, New York
Študije za Mielodisplastični sindromi v drugih mestih
- Houston, TX43 študij
- Baldwin Park, CA26 študij
- Seattle, WA21 študij
- Washington, DC20 študij
- Tampa, FL19 študij
- Boston, MA19 študij
- Miami, FL17 študij
- Durham, NC14 študij
- Columbus, OH14 študij
- St. Louis, MO13 študij
- Atlanta, GA13 študij
- Chicago, IL13 študij
Druge študije v New York City
- Rak dojke136 študij
- Nemalicelični pljučni rak121 študij
- Rak (vse vrste)109 študij
- Rak prostate103 študij
- Metastatski rak93 študij
- Kolorektalni rak78 študij
- Rak jajčnikov69 študij
- Rak pljuč60 študij
- Množni mielom60 študij
- Rak trebušne slinavke60 študij
- Rak endometrija52 študij
- Akutna mieločna levkemija51 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.